Wellmedr vs HumeCare+ — Price, protocol, and guarantees compared
Wellmedr vs HumeCare+ pits a lower-cost, medication-focused model against a higher-price protocol that bundles supportive ingredients, body-composition scanning, and clinician access. Early verdict: Wellmedr is focused on lower starting prices and lifetime locked-in pricing, while HumeCare+ prioritizes a bundled protocol and body-composition tracking with a money-back promise.
Direct difference 1: Starting price and pricing model
Wellmedr lists semaglutide plans “from $89/mo” and advertises lifetime locked-in pricing and no dose-based price increases. HumeCare+ lists semaglutide “from $199/month” and tirzepatide protocols from $299/month. HumeCare+ notes its pricing reflects a promotional discount that may change, while Wellmedr highlights lifetime locked-in pricing and New Customer offers such as “$150 off for Life” in captured marketing copy. Both require verification of eligibility and clinician approval.
Direct difference 2: Bare medication versus bundled protocol
Wellmedr positions itself as offering GLP-1 plans and specific medication options (semaglutide, tirzepatide) with monthly shipping and claims like same-day review plus free overnight shipping on captured pages. HumeCare+ sells a protocol: physician-prescribed compounded semaglutide or tirzepatide combined with glycine, vitamin B12 and B6, an app, and monthly body-composition scans intended to address muscle loss and side effects.
What the bundle means in practice
HumeCare+ explicitly bundles supportive ingredients and body-composition scanning and promotes continuous physician optimization, 24/7 clinician access, and an app for tracking. Wellmedr emphasizes medication plans, locked pricing, and shipping cadence but does not present the same bundled supportive components in the supplied evidence.
See HumeCare+ protocols and scanning
Direct difference 3: Guarantees and refund promises
Wellmedr’s captured marketing includes a “MONEY BACK GUARANTEE” claim: “IF YOU DON’T LOSE WEIGHT IN 90 DAYS WE WILL REFUND 100% OF YOUR MONEY” in landing-page evidence. HumeCare+ advertises a “10%-or-your-money-back promise over six months” with a note to check full terms and eligibility. Both providers present these as promotional or conditional offers and include instructions to verify terms and conditions.
Direct difference 4: Clinical oversight, tracking, and support
HumeCare+ emphasizes physician-prescribed dosing, unlimited clinician access, a U.S. care team available 24/7, and an app for medication tracking and food logging. Wellmedr notes treatment plans require medical evaluation and clinician approval and advertises same-day review on captured pages, but the supplied evidence does not describe the same ongoing tracking features or 24/7 clinician access.
Safety and regulatory notice
Both providers’ captured evidence includes the regulatory note that compounded medications are dispensed from U.S. pharmacies licensed and inspected by state Boards of Pharmacy and that compounded medications are not evaluated by the FDA for safety, effectiveness, or quality. HumeCare+ also notes GLP-1 drugs carry serious risks including a boxed warning for thyroid C-cell tumors; Wellmedr’s captured evidence similarly lists risks including thyroid C-cell tumors and medullary thyroid carcinoma and urges seeking care for specific symptoms.
Comparison table
| Criteria | Wellmedr | HumeCare+ |
|---|---|---|
| Starting price | Semaglutide from $89/mo | Semaglutide from $199/mo; tirzepatide from $299/mo |
| Pricing model | Lifetime locked-in pricing; no dose-based price increases | Promotional pricing noted; may change |
| Protocol type | Medication-focused plans, monthly shipping | Bundled protocol: GLP-1 plus glycine, B12, B6, app, scans |
| Tracking and clinician access | Same-day review noted; clinician approval required | Body-composition scans, app, 24/7 clinician access |
| Refund promise | 90-day money-back claim captured in marketing | 10%-or-your-money-back promise over six months; see terms |
| Regulatory note | Compounded meds not FDA-evaluated; state-licensed pharmacies | Compounded meds not FDA-evaluated; state-licensed pharmacies |
How to choose: key decision points
Price sensitivity: If starting price and a medication-focused plan matter most, Wellmedr lists semaglutide “from $89/mo” and advertises lifetime locked pricing. Support and outcomes focus: If you want a protocol that adds glycine and B vitamins, monthly body-composition scans, continuous clinician access, and a 10%-or-money-back promise, HumeCare+ positions itself around those features.
Compare WellMedr plans and shipping
Explore HumeCare+ tracking and protocol
Conclusion
Wellmedr vs HumeCare+ comes down to lower starting price and lifetime locked pricing at Wellmedr versus the bundled protocol, body-composition tracking, and clinician-focused support at HumeCare+. Both rely on clinician review and both note that compounded medications are not FDA-evaluated. Verify eligibility, documentation requirements, refund terms, and state availability directly with each provider before enrolling.
Choose Wellmedr if you prioritize lower starting costs, lifetime locked-in pricing, and medication-focused monthly plans. Choose HumeCare+ if you want a bundled GLP-1 protocol with glycine and B vitamins, monthly body-composition scans, ongoing clinician access, and the 10%-or-money-back promise.